Results 231 to 240 of about 927,791 (328)

Trends in Smoldering Myeloma Incidence in the United States From Cancer Registries, 2012–2022

open access: yes
American Journal of Hematology, EarlyView.
Rong Wang   +9 more
wiley   +1 more source

Surfactant‐Enhanced Electrospun Nanofiber Filters for Efficient Viral and Bacterial Inactivation

open access: yesJournal of Applied Polymer Science, EarlyView.
In this work, electrospun polyacrylonitrile (PAN) nanofibrous filters functionalized with surfactants (CTAB, CPC, and SDS) were developed for air filtration applications. The PAN nanofiber mats enable efficient particulate matter capture while simultaneously providing antimicrobial and antiviral activity against bacteria (E. coli and S.
Edilton N. da Silva   +9 more
wiley   +1 more source

Editorial: Advances in infectious disease research: tackling antimicrobial resistance, zoonoses, and more

open access: yesFrontiers in Cellular and Infection Microbiology
Priyanka Bhoj   +4 more
doaj   +1 more source

Enhancing clinical microbiology for genomic surveillance of antimicrobial resistance implementation in Africa. [PDF]

open access: yesAntimicrob Resist Infect Control
Kajumbula HM   +13 more
europepmc   +1 more source

CLINICAL MICROBIOLOGY REVIEWS [PDF]

open access: yesClinical Microbiology Reviews, 2007
openaire   +1 more source

Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?

open access: yesArthritis &Rheumatology, EarlyView.
Objective Lupus nephritis (LN) is characterized by a variable disease course, necessitating continuous monitoring. There is an urgent need to identify noninvasive biomarkers. By reviewing and critically assessing the quality of existing studies on LN biomarkers correlating with histopathology, we here explore the challenges in promoting their use in ...
Valentina Querin   +11 more
wiley   +1 more source

Identification of histone deacetylase inhibitor targeting type I interferon and B‐cell abnormalities in systemic lupus erythematosus

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama   +16 more
wiley   +1 more source

Diagnostic testing and laboratory equity in clinical microbiology. [PDF]

open access: yesMicrobiol Spectr
Larkin PMK   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy